BIO – Bio-Rad Laboratories, Inc.
Float Short %
5.47
Margin Of Safety %
-18
Put/Call OI Ratio
0.38
EPS Next Q Diff
0.2
EPS Last/This Y
75
EPS This/Next Y
0.64
Price
280.09
Target Price
332
Analyst Recom
1.78
Performance Q
20.62
Relative Volume
0.78
Beta
0.98
Ticker: BIO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | BIO | 285.69 | 1.76 | 3.50 | 2975 |
| 2025-08-18 | BIO | 284.51 | 0.37 | 1.00 | 465 |
| 2025-08-19 | BIO | 288.13 | 0.36 | 999.99 | 464 |
| 2025-08-20 | BIO | 288.14 | 0.37 | 0.50 | 465 |
| 2025-08-21 | BIO | 284.89 | 0.37 | 0.50 | 465 |
| 2025-08-22 | BIO | 303.8 | 0.38 | 0.22 | 469 |
| 2025-08-25 | BIO | 297.3 | 0.38 | 1.50 | 468 |
| 2025-08-26 | BIO | 296.65 | 0.38 | 1.50 | 468 |
| 2025-08-27 | BIO | 292.81 | 0.38 | 0.33 | 472 |
| 2025-08-28 | BIO | 293.67 | 0.38 | 0.00 | 475 |
| 2025-08-29 | BIO | 297.86 | 0.38 | 0.00 | 475 |
| 2025-09-02 | BIO | 290.79 | 0.38 | 0.00 | 475 |
| 2025-09-03 | BIO | 288.49 | 0.38 | 0.00 | 475 |
| 2025-09-04 | BIO | 289.74 | 0.38 | 0.00 | 475 |
| 2025-09-05 | BIO | 295.24 | 0.39 | 0.00 | 471 |
| 2025-09-08 | BIO | 290.55 | 0.38 | 0.67 | 476 |
| 2025-09-09 | BIO | 285.77 | 0.38 | 0.67 | 476 |
| 2025-09-10 | BIO | 276.91 | 0.38 | 0.67 | 476 |
| 2025-09-11 | BIO | 286.09 | 0.37 | 0.00 | 476 |
| 2025-09-12 | BIO | 279.94 | 0.38 | 1.00 | 473 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | BIO | 285.72 | -2.8 | -186.2 | 9.65 |
| 2025-08-18 | BIO | 284.55 | -2.8 | -186.1 | 9.65 |
| 2025-08-19 | BIO | 288.37 | -2.8 | -181.0 | 9.65 |
| 2025-08-20 | BIO | 288.02 | -2.8 | -184.7 | 9.65 |
| 2025-08-21 | BIO | 284.97 | -2.8 | -187.8 | 9.65 |
| 2025-08-22 | BIO | 303.73 | -2.8 | -164.5 | 9.65 |
| 2025-08-25 | BIO | 297.37 | -2.8 | -188.3 | 9.65 |
| 2025-08-26 | BIO | 296.60 | -2.8 | -183.5 | 9.65 |
| 2025-08-27 | BIO | 292.96 | -2.8 | -186.7 | 9.65 |
| 2025-08-28 | BIO | 293.67 | -2.8 | -182.0 | 9.65 |
| 2025-08-29 | BIO | 298.05 | -2.8 | -178.1 | 9.65 |
| 2025-09-02 | BIO | 290.67 | -2.8 | -190.3 | 9.65 |
| 2025-09-03 | BIO | 288.25 | -2.8 | -182.5 | 9.65 |
| 2025-09-04 | BIO | 289.43 | -2.8 | -178.3 | 9.65 |
| 2025-09-05 | BIO | 295.43 | -3.3 | -173.5 | 9.64 |
| 2025-09-08 | BIO | 290.38 | -3.3 | -184.4 | 9.64 |
| 2025-09-09 | BIO | 285.89 | -3.3 | -191.3 | 9.64 |
| 2025-09-10 | BIO | 276.65 | -3.3 | -197.4 | 9.64 |
| 2025-09-11 | BIO | 285.90 | -3.3 | -179.0 | 9.64 |
| 2025-09-12 | BIO | 280.09 | -3.3 | -195.3 | 9.64 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | BIO | -0.03 | 3.54 | 5.01 |
| 2025-08-18 | BIO | -0.03 | 2.90 | 5.01 |
| 2025-08-19 | BIO | -0.03 | 2.90 | 5.01 |
| 2025-08-20 | BIO | -0.03 | 2.90 | 5.01 |
| 2025-08-21 | BIO | -0.03 | 2.90 | 5.01 |
| 2025-08-22 | BIO | -0.03 | 2.90 | 5.01 |
| 2025-08-25 | BIO | -0.03 | -1.34 | 5.01 |
| 2025-08-26 | BIO | -0.03 | -1.34 | 5.01 |
| 2025-08-27 | BIO | -0.03 | -1.34 | 5.46 |
| 2025-08-28 | BIO | -0.03 | -1.34 | 5.46 |
| 2025-08-29 | BIO | -0.03 | -1.34 | 5.46 |
| 2025-09-02 | BIO | -0.03 | -1.14 | 5.46 |
| 2025-09-03 | BIO | -0.03 | -1.14 | 5.46 |
| 2025-09-04 | BIO | -0.03 | -1.14 | 5.46 |
| 2025-09-05 | BIO | -0.03 | -1.14 | 5.46 |
| 2025-09-08 | BIO | -0.03 | -1.01 | 5.46 |
| 2025-09-09 | BIO | -0.03 | -1.01 | 5.46 |
| 2025-09-10 | BIO | -0.03 | -1.01 | 5.46 |
| 2025-09-11 | BIO | -0.03 | -1.01 | 5.47 |
| 2025-09-12 | BIO | -0.03 | -1.01 | 5.47 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.61
Avg. EPS Est. Current Quarter
1.94
Avg. EPS Est. Next Quarter
2.81
Insider Transactions
-0.03
Institutional Transactions
-1.01
Beta
0.98
Average Sales Estimate Current Quarter
651
Average Sales Estimate Next Quarter
707
Fair Value
228.69
Quality Score
82
Growth Score
37
Sentiment Score
41
Actual DrawDown %
66.4
Max Drawdown 5-Year %
-73.8
Target Price
332
P/E
23.89
Forward P/E
25.91
PEG
4.69
P/S
2.97
P/B
1.06
P/Free Cash Flow
20.46
EPS
11.73
Average EPS Est. Cur. Y
9.64
EPS Next Y. (Est.)
10.28
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
12.5
Relative Volume
0.78
Return on Equity vs Sector %
-20.4
Return on Equity vs Industry %
-14.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
-195.3
Bio-Rad Laboratories, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 7700
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today
news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance
stock history BIO – Bio-Rad Laboratories, Inc. invest stock market
stock prices BIO premarket after hours
ticker BIO fair value insiders trading